Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.031 | 0.5 |
mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.0088 | 0.8 |
mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |